Zobrazeno 1 - 10
of 13
pro vyhledávání: '"L Fructuoso"'
Autor:
J Ibanez-Caturla, P Torrano Belmonte, L Fructuoso González, JA Gutiérrez Sánchez, M Hernández Sánchez, P Pacheco López, MÁ Carvajal Sánchez, M Guillén Díaz, A Martínez Orea, MD Najera-Perez
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0987294c9abeba4151a5d7ed1b1eb3d
https://doi.org/10.1136/ejhpharm-2023-eahp.116
https://doi.org/10.1136/ejhpharm-2023-eahp.116
Autor:
M Hernández Sánchez, MD Nájera Pérez, JA Gutiérrez Sánchez, MA Carvajal Sánhez, P Torrano Belmonte, J Ibanez-Caturla, L Fructuoso Gonzalez, M Guillén Díaz, P Pacheco López, A Martinez Orea
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7be7589a91354215a2e50793f7dcfea2
https://doi.org/10.1136/ejhpharm-2023-eahp.78
https://doi.org/10.1136/ejhpharm-2023-eahp.78
Autor:
J Ibanez-Caturla, P Torrano-Belmonte, L Fructuoso-González, JA Gutiérrez Sánchez, P Pacheco López, MÁ Carvajal Sánchez, M Guillén Díaz, A Martínez Orea, J León Villar, JC Titos Arcos
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::654bb188e5ae0a5f188e7141a3a5c30e
https://doi.org/10.1136/ejhpharm-2023-eahp.92
https://doi.org/10.1136/ejhpharm-2023-eahp.92
Autor:
P Torrano-Belmonte, L Fructuoso- González, J Ibanez-Caturla, M Hernandez-Sánchez, JA Gutierrez-Sánchez, M Guillén-Diaz, A Martínez-Orea, P Pacheco-Lopez, MA Carvajal-Sanchez, M Ventura-Lopez
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24512e5d2a3befa2e8f6738256a2d5fe
https://doi.org/10.1136/ejhpharm-2023-eahp.87
https://doi.org/10.1136/ejhpharm-2023-eahp.87
Autor:
L Fructuoso, P Torrano Belmonte, J Ibañez Caturla, P Pacheco Lopez, MA Carvajal-Sanchez, S Clavijos Bautista, C Fernández Zamora, M Hernandez Sanchez, JA Gutierrez Sanchez
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9c237d8ee56f07f2ca3b3ce7d52757f
https://doi.org/10.1136/ejhpharm-2022-eahp.105
https://doi.org/10.1136/ejhpharm-2022-eahp.105
Autor:
MA Carvajal-Sanchez, MD Najera-Perez, P Pacheco-Lopez, J Ibañez-Caturla, L Fructuoso-Gonzalez, P Torrano-Belmonte, JA Gutierrez-Sanchez, M Hernandez-Sanchez, A Bolufer-Perez, J Plaza-Aniorte, J Leon-Villar
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb32a82a96d3340c6927dc90dde4a1bf
https://doi.org/10.1136/ejhpharm-2022-eahp.84
https://doi.org/10.1136/ejhpharm-2022-eahp.84
Autor:
P Pacheco, MÁ Carvajal, J Ibañez, MT Alonso, M Tobaruela, L Fructuoso, P Torrano, JA Gutierrez, M Hernández
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe2808a655c4cb661a25418352b70e55
https://doi.org/10.1136/ejhpharm-2022-eahp.324
https://doi.org/10.1136/ejhpharm-2022-eahp.324
Autor:
J Ibanez-Caturla, P Pacheco, T Alonso-Domínguez, MA Carvajal-Sánchez, L Fructuoso-González, P Torrano-Belmonte, M Hernández-Sánchez, JA Gutiérrez Sánchez, S Clavijos-Bautista, C Fernández-Zamora, MA Meroño-Saura
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a43a06ceb6593f51fdfeab42f0782c3
https://doi.org/10.1136/ejhpharm-2022-eahp.80
https://doi.org/10.1136/ejhpharm-2022-eahp.80
Autor:
MA Carvajal-Sanchez, A Machado-Leon, J Leon-Villar, P Pacheco-Lopez, J Ibañez-Caturla, L Fructuoso-Gonzalez, P Torrano-Belmonte, M Hernandez-Sanchez, JA Gutierrez-Sanchez, J Plaza-Aniorte
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2672596952156767476bed818e32717
https://doi.org/10.1136/ejhpharm-2022-eahp.92
https://doi.org/10.1136/ejhpharm-2022-eahp.92
Autor:
Nájera-Pérez, Má Carvajal-Sánchez, L Fructuoso-González, S Clavijos-Bautista, MA Meroño-Saura, C Fernández Zamora, J Ibañez-Caturla, P Torrano-Belmonte, P Pacheco-López
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance The medicines under additional monitoring (MUAMs), identified with a black inverted triangle (d), are subject to strict control for 5 years after their authorisation or until the European Medicines Agency (EMA) considers tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d71bcf9eda5afc4d6e53ffd0fdeb21d
https://doi.org/10.1136/ejhpharm-2021-eahpconf.326
https://doi.org/10.1136/ejhpharm-2021-eahpconf.326